GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ekso Bionics Holdings Inc (LTS:0IFR) » Definitions » Market Cap

Ekso Bionics Holdings (LTS:0IFR) Market Cap : $19.63 Mil (As of Jun. 24, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Ekso Bionics Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Ekso Bionics Holdings's share price for the quarter that ended in Mar. 2024 was $1.335. Ekso Bionics Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 18.10 Mil. Therefore, Ekso Bionics Holdings's market cap for the quarter that ended in Mar. 2024 was $24.16 Mil.

Ekso Bionics Holdings's quarterly market cap increased from Sep. 2023 ($10.06 Mil) to Dec. 2023 ($38.10 Mil) but then declined from Dec. 2023 ($38.10 Mil) to Mar. 2024 ($24.16 Mil).

Ekso Bionics Holdings's annual market cap declined from Dec. 2021 ($37.65 Mil) to Dec. 2022 ($22.66 Mil) but then increased from Dec. 2022 ($22.66 Mil) to Dec. 2023 ($38.10 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ekso Bionics Holdings's Enterprise Value for Today is $17.67 Mil.


Ekso Bionics Holdings Market Cap Historical Data

The historical data trend for Ekso Bionics Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ekso Bionics Holdings Market Cap Chart

Ekso Bionics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.84 54.85 37.65 22.66 38.10

Ekso Bionics Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.86 18.55 10.06 38.10 24.16

Competitive Comparison of Ekso Bionics Holdings's Market Cap

For the Medical Instruments & Supplies subindustry, Ekso Bionics Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ekso Bionics Holdings's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ekso Bionics Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Ekso Bionics Holdings's Market Cap falls into.



Ekso Bionics Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Ekso Bionics Holdings's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=$2.5658*14.848
=$38.10

Ekso Bionics Holdings's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=$1.335*18.096
=$24.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ekso Bionics Holdings  (LTS:0IFR) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Ekso Bionics Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of Ekso Bionics Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Ekso Bionics Holdings (LTS:0IFR) Business Description

Traded in Other Exchanges
Address
101 Glacier Point, Suite A, San Rafael, CA, USA, 94901
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.

Ekso Bionics Holdings (LTS:0IFR) Headlines

No Headlines